Your browser doesn't support javascript.
loading
Activity and safety of first-line treatments for advanced melanoma: A network meta-analysis.
Boutros, Andrea; Tanda, Enrica Teresa; Croce, Elena; Catalano, Fabio; Ceppi, Marcello; Bruzzone, Marco; Cecchi, Federica; Arecco, Luca; Fraguglia, Matteo; Pronzato, Paolo; Genova, Carlo; Del Mastro, Lucia; Lambertini, Matteo; Spagnolo, Francesco.
Afiliación
  • Boutros A; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy. Electronic address: boutros.andrea@gmail.com.
  • Tanda ET; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Croce E; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.
  • Catalano F; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.
  • Ceppi M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Bruzzone M; Clinical Epidemiology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Cecchi F; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Arecco L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Fraguglia M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.
  • Pronzato P; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Genova C; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Del Mastro L; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O.C. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Spagnolo F; Department of Medical Oncology, Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Surgical Sciences and Integrated Diagnostics (DISC), Plastic Surgery, University of Genova, Genoa, Italy.
Eur J Cancer ; 188: 64-79, 2023 07.
Article en En | MEDLINE | ID: mdl-37196485
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nivolumab / Melanoma Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Nivolumab / Melanoma Tipo de estudio: Clinical_trials / Systematic_reviews Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2023 Tipo del documento: Article